BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12108035)

  • 1. [Guidelines and minimal diagnostic criteria for the histological diagnosis of endocrine tumors of the gastroenteropancreatic type].
    Rindi G; Capella C; Bordi C; Solcia E;
    Pathologica; 2002 Jun; 94(3):142-7. PubMed ID: 12108035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract.
    Rindi G; Capella C; Solcia E
    Q J Nucl Med; 2000 Mar; 44(1):13-21. PubMed ID: 10932598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators.
    Ardill JE; O'Dorisio TM
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):777-90. PubMed ID: 21095544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of calcium provocative test in the diagnosis of gastroenteropancreatic endocrine tumors.
    Vezzadini C; Poggioli R; Casoni I; Vezzadini P
    Panminerva Med; 1996 Dec; 38(4):255-8. PubMed ID: 9063035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of neuroendocrine tumors: a meeting of experts from Latin America.
    Costa F; Domenichini E; Garavito G; Medrano R; Mendez G; O'Connor J; Rojas W; Torres S; Younes RN; Delle Fave G; Oberg K
    Neuroendocrinology; 2008; 88(3):235-42. PubMed ID: 18663282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical diagnosis of gastroenteropancreatic endocrine tumors.
    Tartaglia A; Bianchini S; Vezzadini P
    Minerva Med; 2003 Feb; 94(1):1-7. PubMed ID: 12719697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroenteropancreatic endocrine tumors: clinical characterization before therapy.
    Baudin E
    Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):228-39. PubMed ID: 17315031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic criteria and classification of gastro-intestinal pancreatic endocrine tumors].
    Capella C; Uccella S; Albarello L; Feltri M; La Rosa S
    Minerva Endocrinol; 2001 Sep; 26(3):103-10. PubMed ID: 11753231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New perspectives in diagnosis and therapy of endocrine gastroenteropancreatic (GEP) tumors with somatostatin analogues].
    Rubello D; Rufini V; De Carlo E; Martini C; Calcagni ML; Sicolo N; Troncone L; Casara D
    Minerva Endocrinol; 2003 Dec; 28(4):259-96. PubMed ID: 14752399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coexistence of two different neuroendocrine tumors of the upper gastrointestinal tract and of the pancreas].
    Ritter MR; Höppner W
    Dtsch Med Wochenschr; 1999 Jun; 124(22):712; discussion 713. PubMed ID: 10394354
    [No Abstract]   [Full Text] [Related]  

  • 11. Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options.
    Arnold R
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):491-505. PubMed ID: 16183523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroendocrine tumors of the gastroenteropancreatic system--reevaluation using the Capella classification].
    Brüwer M; Pahlov-Nejad T; Herbst H; Senninger N; Schürmann G
    Zentralbl Chir; 2003 Aug; 128(8):656-62. PubMed ID: 12931261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview.
    Oberg K; Astrup L; Eriksson B; Falkmer SE; Falkmer UG; Gustafsen J; Haglund C; Knigge U; Vatn MH; Välimäki M;
    Acta Oncol; 2004; 43(7):617-25. PubMed ID: 15545182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foreword: Gastroenteropancreatic system and its tumors: Part 1.
    LeRoith D
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):xiii-xvi. PubMed ID: 21095537
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoreactivity and expression of amylin in gastroenteropancreatic endocrine tumors.
    Eissele R; Neuhaus C; Trautmann ME; Funk A; Arnold R; Höfler H
    Am J Pathol; 1993 Jul; 143(1):283-91. PubMed ID: 8317551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psammoma bodies in endocrine tumors of the gastroenteropancreatic axis: a rather common occurrence.
    Greider MH; DeSchryver-Kecskemeti K; Kraus FT
    Semin Diagn Pathol; 1984 Feb; 1(1):19-29. PubMed ID: 6599923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histological classification of endocrine tumors of the pancreas].
    Couvelard A; Felce-Dachez M; Degott C
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S15-9. PubMed ID: 12704288
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
    Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
    Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporadically occurring functional pancreatic endocrine tumors: review of recent literature.
    Goldin SB; Aston J; Wahi MM
    Curr Opin Oncol; 2008 Jan; 20(1):25-33. PubMed ID: 18043253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine tumors of the pancreas.
    Simon P; Spilcke-Liss E; Wallaschofski H
    Endocrinol Metab Clin North Am; 2006 Jun; 35(2):431-47, xii. PubMed ID: 16632104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.